Latent tuberculosis infection screening and treatment in HIV: insights from evaluation of UK practice.
Thorax
; 72(2): 180-182, 2017 02.
Article
in En
| MEDLINE
| ID: mdl-27742873
ABSTRACT
Latent TB infection (LTBI) screening and treatment in HIV-positive individuals in the UK is advocated by the British HIV Association (BHIVA) and National Institute for Health and Care Excellence (NICE), although each recommends differing strategies. We undertook an evaluation of UK practice, relating the responses to the local HIV/TB disease burden. 162 of 188 (86%) UK geographical areas responded; only 93/162 (57.4%) offer LTBI testing with considerable heterogeneity in practice, and no difference in HIV/TB burden between areas offering testing and those who do not. Only 33/93 (35.5%) and 6/93 (6.5%) reported full compliance with BHIVA and NICE guidance respectively. A uniform national guideline is required.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Mass Screening
/
AIDS-Related Opportunistic Infections
/
Latent Tuberculosis
Type of study:
Diagnostic_studies
/
Evaluation_studies
/
Guideline
/
Incidence_studies
/
Prevalence_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Limits:
Adult
/
Female
/
Humans
/
Male
Country/Region as subject:
Europa
Language:
En
Journal:
Thorax
Year:
2017
Document type:
Article
Affiliation country:
United kingdom